We are so excited to reveal our newest collaboration with… 🥁🥁🥁🥁🥁🥁🥁🥁🥁🥁🥁🥁🥁🥁 Google Cloud! We are exploring the use of Google’s GenAI tools, including Med-PaLM 2 to improve patient engagement and boost the clinical capacity of healthcare professionals. Read more here: https://lnkd.in/evs6hf8y #humaforhealth #AIinhealthcare #healthcareAI #AIatHuma #digitalhealth #healthtech #medtech #healthcare #GoogleCloud
Huma
Software Development
Global digital health company powering hospital at home virtual care, DCTs and digital companion apps
About us
Huma is a global digital health technology company that uses AI to advance digital-first care delivery and research to help people live longer, fuller lives. Huma's regulated Software as a Medical Device is the only disease agnostic platform to hold both EU MDR Class IIb and US FDA Class II regulatory status. It powers: - Digital first care for health systems - Companion apps to support patients through treatment and drug therapies - Virtual clinical trials to accelerate research Please visit www.huma.com to learn more.
- Website
-
http://www.huma.com
External link for Huma
- Industry
- Software Development
- Company size
- 501-1,000 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 2011
- Specialties
- Digital clinical trials, Remote patient monitoring, and Digital companion apps
Locations
-
Primary
Millbank Tower, 21-24 Millbank
London, SW1P 4QP, GB
-
WeWork Financial Centre
Medopad
Shanghai, CN
-
The Genome Center, 101 Avenue of the Americas
New York City, US
-
Raboisen 32
Hamburg, HH 20095, DE
Employees at Huma
Updates
-
Huma is committed to delivering digital innovation that can transform the cancer patient experience. We’re immensely proud to announce that Huma has been selected as the winner of the Macmillan Innovation Challenge for our Systemic Anti-Cancer Therapy (SACT) Digital Checklist app, aimed at enhancing the experience of cancer patients and improving clinical workflows. The SACT Digital Checklist makes it easy for patients to share their health information with care teams from the comfort of their homes, enabling clinicians to review this data remotely and determine if patients are ready for medication. The app is designed to increase clinical capacity for delivering treatment, improve the patient experience, and reduce stress for cancer patients. With the support of Macmillan Cancer Support, Health Innovation East, Health Innovation Yorkshire & Humber, Health Innovation Kent Surrey Sussex and clinical teams from East Suffolk and North Essex NHS Foundation Trust, we hope to make the SACT Digital Checklist available across the NHS. Hear more about this innovative solution from Huma's Tobias Alpsten, the Macmillan Cancer Support team, Health Innovation East, and from patients themselves: https://lnkd.in/eD7YAh-M Learn more: https://lnkd.in/eN5Wk-mG
-
Over 700,000 people worldwide are living with Myasthenia Gravis (MG), a rare neuromuscular disease. In time for #MGAwarenessMonth, Huma is proud to introduce HumaMG, an innovative digital care platform designed specifically to help patients and their care teams monitor and manage the effects of MG. HumaMG makes it easy for patients to track their symptoms, receive timely reminders for their medication, and access educational resources tailored to their condition. Care teams can remotely monitor patient progress, identify potential issues early, and adjust treatments accordingly. We’re proud to be working with people living with MG, patient advocacy groups, and key opinion leaders in the MG space to continually enhance HumaMG, making it even more suited to the unique needs of MG patients and care teams. Together, we can make a meaningful difference in the lives of patients and their families. Myasthenia Gravis Foundation of America, Inc. #MGawareness #MyastheniaGravis #HumaMG #HealthTech
-
-
Huma's VP of Machine Learning and Imaging, Dr. Benjamin Irving, will be speaking at the HealthXL Global Gathering 2024 on the topic 'AI-Impact: How AI is changing life sciences and healthcare.' Alongside fellow panellists Cristina Ortega Duran, Matthias Essenpreis, Janet Munro and Stephen R., Ben will be sharing insights from Huma's applications of #AI and #GenAI in patient identification, tracking disease progression, expanding clinical capacity, and more. For more information, visit: https://bit.ly/3UF823P __________ Date: 17 June 2024 Time: 12-5pm CEST Location: RAI Convention Centre, Amsterdam ________
-
-
Huma is on the verge of reaching 3 million users 🎉 Can you guess when we'll get there? We're offering a cash prize if you can correctly guess the day, hour, and minute that we'll hit 3 million users. Enter your best guess here: https://lnkd.in/e_F3cnuy
-
-
Huma and Bayer are proud to announce the launch of the Bayer Aspirin Heart Health Risk Assessment tool in Saudi Arabia, where reducing the impact of cardiovascular disease is a key priority of the #Vision2030 national strategy. The tool, which was launched in the US last year, uses an algorithm based on data from over 500k individuals to deliver an assessment of 10-year risk for cardiovascular disease: without the need for a blood test or blood pressure measurement. By bringing risk awareness into the home, we aim to give a boost to national-level cardiovascular disease prevention programs and reduce the impact of heart attack and stroke. Read more: https://lnkd.in/ePgkWCrJ #hearthealth Bayer | Consumer Health
-
-
We're thrilled to announce the launch of our bladder cancer treatment companion app, developed collaboratively with Merck Healthcare. The app aims to support patients and caregivers in navigating a complex treatment pathway, and has been launched in the UK just in time for #BladderCancerAwarenessMonth. Read more here: https://lnkd.in/gFJ-XpYE #humaforhealth #digitalhealth #oncology #healthcare #SaMD #worldsbestdigitalhealthcompanies #softwareasamedicaldevice
-
-
We're pleased to share that Huma has been recognised as one of the World's Best Digital Health Companies by Newsweek and Statista in their inaugural ranking. Learn more: https://lnkd.in/gsjf7JTU
-
-
Huma's CEO Dan Vahdat will be attending the World Economic Forum Special Meeting on Global Collaboration, Growth and Energy for Development in Riyadh, Saudi Arabia. Huma recently achieved Saudi FDA Class C regulatory clearance and will be announcing further investment in support of Vision 2030. Learn more: https://lnkd.in/eCepz746 #SpecialMeeting24
-